| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/26/2007 | WO2007046642A1 Composition comprising an extract of pine needle for preventing and treating human disease caused by viruses and the use thereof |
| 04/26/2007 | WO2007045877A1 4-heteroarymethyl substituted phthalazinone derivatives |
| 04/26/2007 | WO2007045573A1 Phenyl-acetamide nnrt inhibitors |
| 04/26/2007 | WO2007045096A1 Oligoheteroaromatic luminiscent assemblies as high-affinity dna sequence-directed ligands |
| 04/26/2007 | WO2007045009A1 Microbicidal dendrimer composition delivery system |
| 04/26/2007 | WO2007027230A3 Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses |
| 04/26/2007 | WO2007026024A3 Benzodiazepines as hcv inhibitors |
| 04/26/2007 | WO2007025098A3 Triazole compounds and methods of making and using the same |
| 04/26/2007 | WO2007021721A3 Glycomimetic inhibitors of the pa-il lectin, pa-iil lectin or both the lectins from pseudomonas |
| 04/26/2007 | WO2006131833A3 New hybrid oligomers. their preparation process and pharmaceutical compositions containing them |
| 04/26/2007 | WO2006122139A3 Use of tfpi to treat severe bacterial infections |
| 04/26/2007 | WO2006121422A8 Antibodies against clostridium difficile toxins and uses thereof |
| 04/26/2007 | WO2006059247A8 VACCINES, COMPOSITIONS AND METHODS BASED ON STAPHYLOCOCCUS AUREUS IRON-REGULATED SURFACE DETERMINANTS IsdA, IsdB, and IsdC |
| 04/26/2007 | WO2006050930A3 Conjugates with enhanced cell uptake activity |
| 04/26/2007 | WO2006042724A3 Magnetic particles for therapy and diagnosis |
| 04/26/2007 | US20070093553 HMB compositions and uses thereof |
| 04/26/2007 | US20070093511 Anhydrous Crystal Form of Valaciclovir Hydrochloride |
| 04/26/2007 | US20070093510 Phosphodiesterase 4 inhibitors |
| 04/26/2007 | US20070093445 RNA interference mediating small RNA molecules |
| 04/26/2007 | US20070093434 Regulation of food intake and glucose production by modulation of long-chain fatty acyl-coa levels in the hypothalamus |
| 04/26/2007 | US20070093416 Human beta-defensin secretion promoter |
| 04/26/2007 | US20070092944 glycosylation endproducts of polyketides, glycoproteins or polyketide-peptide substrates with microbial glycosyltransferases |
| 04/26/2007 | US20070092540 Carboxylate-gated-nitroxide (cgn) compounds and compositions and methods of use thereof |
| 04/26/2007 | US20070092536 Cold-adapted equine influenza viruses |
| 04/26/2007 | US20070092523 Combination Therapy Of Respiratory Diseases Using Antibodies |
| 04/26/2007 | US20070092511 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells |
| 04/26/2007 | CA2626556A1 Antibody-based therapeutics with enhanced adcc activity |
| 04/26/2007 | CA2626105A1 Microbicidal dendrimer composition delivery system |
| 04/26/2007 | CA2625047A1 Phenyl-acetamide nnrt inhibitors |
| 04/26/2007 | CA2623703A1 4-heteroarylmethyl substituted phthalazinone derivatives |
| 04/25/2007 | EP1777236A1 Modified saccharides having improved stability in water |
| 04/25/2007 | EP1777233A2 Gonococcal proteins and nucleic acids |
| 04/25/2007 | EP1776962A1 Vaccine |
| 04/25/2007 | EP1776961A1 Immunizing against HIV infection |
| 04/25/2007 | EP1776387A1 Angiogenic and immunologic applications of anti-cd160 specific compounds obtainable from mab cl1-r2 |
| 04/25/2007 | EP1776368A1 Inhibitors of hcv replication |
| 04/25/2007 | EP1776362A1 Spiro compounds and methods for the modulation of chemokine receptor activity |
| 04/25/2007 | EP1776140A2 Methods of inhibiting viral replication |
| 04/25/2007 | EP1776109A1 Pharmaceutical formulation comprising an antibiotic, a triazole and a corticosteroid |
| 04/25/2007 | EP1776105A2 Methods and compositions for inducing innate immune responses |
| 04/25/2007 | EP1539147A4 Methods of treating microbial infections in humans and animals |
| 04/25/2007 | EP1487834B1 Aza-bicyclic n-biarylamides with affinity for the alpha-7 nicotinic acetylcholine receptor |
| 04/25/2007 | EP1425042B1 Complement pathway inhibitors binding to c5 and c5a without preventing the formation of c5b |
| 04/25/2007 | EP1305294B1 Imidazolyl derivatives |
| 04/25/2007 | EP1210336B1 Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase |
| 04/25/2007 | EP1135025B1 Plasmid maintenance system for antigen delivery |
| 04/25/2007 | EP0866656B1 Use of n-substituted pyridones as tumor necrosis factor alpha inhibitors |
| 04/25/2007 | CN1953985A Prodrugs of piperazine and substituted piperidine antiviral agents |
| 04/25/2007 | CN1953982A 4-substituted 1,5-dihydro-pyrido(3,2-b)indol-2-ones |
| 04/25/2007 | CN1953978A 5-substituted 1-phenyl-1,5-dihydro-pyrido[3,2-b] indol-2-ones and analogs as anti-virals |
| 04/25/2007 | CN1953759A Use of the mushroom agaricus blazei murill for the production of medicaments suitable for treating infections and allergies |
| 04/25/2007 | CN1953751A Combinations of substituted 1-phenyl-1,5-dihydro-pyrido- [3,2-b] indol-2-ones and other HIV inhibitors |
| 04/25/2007 | CN1953750A Novel uses for proton pump inhibitors |
| 04/25/2007 | CN1952146A Expression separation and purification method for Chinese Phytolacca acinosa cDNA mutant and TAT gene recombinant in prokaryon and application therefor |
| 04/25/2007 | CN1952134A Polynucleotide promoting activity of human transcription factor NF-kappa B and its encoded polypeptide and application |
| 04/25/2007 | CN1951957A Gene MgPTH12 for controlling mature and pathogenicity of fungi appressorium derived from Magnaporthe grisea and its uses |
| 04/25/2007 | CN1951939A Novel pyrrole derivatives as pharmaceutical agents |
| 04/25/2007 | CN1951932A [N-(3',4'methylenedioxy)phenylethyl] formamidobenzoic acid derivative, its preparation method and uses |
| 04/25/2007 | CN1951907A Compound and its preparation method and its application in pharmacy |
| 04/25/2007 | CN1951499A A cell mediated immunity vaccine and preparation method thereof |
| 04/25/2007 | CN1951494A Compound Chinese medicinal preparation for treating affection of external wind and cold and preparation method thereof |
| 04/25/2007 | CN1951486A A medicament for treating bacterial infection of urinary tract and preparation method thereof |
| 04/25/2007 | CN1951485A An antivirus medicament |
| 04/25/2007 | CN1951459A Medicament for matching with holographic fire burning therapy in acupoints and preparation method thereof |
| 04/25/2007 | CN1951413A Medicament for preventing and treating turtle disease and preparation method thereof |
| 04/25/2007 | CN1951412A Nitric oxide and its biomedical significance |
| 04/25/2007 | CN1951411A Nitric oxide and its biomedical significance |
| 04/25/2007 | CN1951401A Solid liposome nanoparticles of arenobufagin and preparation method thereof |
| 04/25/2007 | CN1951400A Arenobufagin nanoliposome and preparation method thereof |
| 04/25/2007 | CN1951390A Pharmaceutical compositions comprising colloidal silicon dioxide |
| 04/25/2007 | CN1951388A Betamethasone sodium phosphate powder injection and preparation method thereof |
| 04/25/2007 | CN1951387A Medicinal combinations composed by Imipenem, Cilastatin and three kinds of sputum removing medicament |
| 04/25/2007 | CN1951386A Medicinal combinations composed by meropenem with three kinds of sputum removing medicament respectively |
| 04/25/2007 | CN1951381A Baicalin solution composition |
| 04/25/2007 | CN1951379A Medicinal combination composed by Fudosteine with nine kinds of antiseptic medicament respectively |
| 04/25/2007 | CN1951224A Edible Korean pine active carbon and preparation method thereof |
| 04/25/2007 | CN1312279C Method for preparing elspar modilfied by carbowax |
| 04/25/2007 | CN1312181C Human monoclonal antibodies to FC Alpha receptor (CD89) |
| 04/25/2007 | CN1312175C Trichosanthin mutant and coding gene thereof |
| 04/25/2007 | CN1312171C DNA vaccines encoding HIV accessory proteins |
| 04/25/2007 | CN1312158C Method for preparing cefixime |
| 04/25/2007 | CN1312152C New purine derivatives |
| 04/25/2007 | CN1312139C Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators |
| 04/25/2007 | CN1312131C Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredent |
| 04/25/2007 | CN1311871C DNA expression vectors and methods of use |
| 04/25/2007 | CN1311870C Interleukin 6 production inhibitor |
| 04/25/2007 | CN1311837C Externally-applied medicine for treating multiple skin diseases and production thereof |
| 04/25/2007 | CN1311831C Antibacterial medicinal composition of enhanced oral absorptivity |
| 04/25/2007 | CN1311830C Cefadroxil oral disintegrant tablet, and its prepn. method |
| 04/25/2007 | CN1311827C 加替沙星软胶囊及其制备方法 Gatifloxacin soft capsule and its preparation method |
| 04/25/2007 | CN1311813C Freeze-dried powder injection of Tianjihuang and its making method |
| 04/25/2007 | CN1311807C Method for preparing gramular preparing for treating hepatitis and method for controlling quality |
| 04/24/2007 | USRE39591 Macrolides with increased acid stability relative to erythromycin A and 6-O-methyl erythromycin A and enhanced activity toward gram negative bacteria and macrolide resistant gram positive bacteria |
| 04/24/2007 | USRE39586 Secreted by the hybridoma cell line deposited in the Cell; Peripheral blood lymphocytes are activated in vitro with pokeweed mitogen and then fused with heteromyeloma cells to generate hybridomas secreting human antibodies |
| 04/24/2007 | US7208655 A plant virus containing a predetermined foreign peptide as part of the coat protein of the virus |
| 04/24/2007 | US7208629 5′-Carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2007 | US7208598 Trans-N2-(4-aminocyclohexyl)-N6-[2-[[[4-choro-3-trifluoromethyl)-phenyl]-methyl]-amino]-ethyl]-9-cyclopentyl-9H-purin-2,6-diamine trihydrochloride; cycline-dependent kinase proteins (cdk) inhibitor; animitotic, antitumor agents |
| 04/24/2007 | US7208582 Polynucleotides codes for antibodies having amino acid sequences selected from complementary determining regions of variable peptides or single chain fragments, used as anticarcinogenic agents |
| 04/24/2007 | US7208513 Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith |
| 04/24/2007 | US7208509 Non-nucleoside reverse transcriptase inhibitors |